drugset / Trial / NCT03466632

Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy

NCT03466632

Phase 3 Unknown 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

Timeline

Start
2016-04-01
Primary completion
2020-04-01
Completion
2020-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg
Comparator Propofol Small molecule 0.5 mg/kg Intravenous

Indications